Open AccessCo-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies
Author(s) -
Yingxin Zhao,
Peng Chen,
Liping Dou,
Fei Li,
Meng Li,
Lingmin Xu,
Jing Chen,
Mingyu Jia,
Sai Huang,
Nan Wang,
Songhua Luan,
Jinling Yang,
Nan Bai,
DaiHong Liu
Publication year - 2022
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s354270
Subject(s) - ruxolitinib , voriconazole , cmax , medicine , pharmacokinetics , aplastic anemia , area under the curve , gastroenterology , pharmacology , bone marrow , myelofibrosis , antifungal , dermatology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom